Hyaluronate – parathyroid hormone peptide conjugate for transdermal treatment of osteoporosis

References

• Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434–1441.10.1056/NEJM200105103441904
   PubMed Web of Science ®Google Scholar
• Brixen KT, Christensen PM, Ejersted C, et al. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol. 2004;94:260–270.10.1111/pto.2004.94.issue-6
   PubMed Web of Science ®Google Scholar
• Marx UC, Adermann K, Bayer P, et al. Solution structures of human parathyroid hormone fragments hPTH(1–34) and hPTH(1–39) and bovine parathyroid hormone fragment bPTH(1–37). Biochem Biophys Res Commun. 2000;267:213–220.10.1006/bbrc.1999.1958
   PubMed Web of Science ®Google Scholar
• Hock D, Mägerlein M, Heine G, et al. Isolation and characterization of the bioactive circulating human parathyroid hormone, hPTH-1-37. FEBS Lett. 1997;400:221–225.10.1016/S0014-5793(96)01390-7
   PubMed Web of Science ®Google Scholar
• Matthew S, Sharon B, Midura RJM. Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair. Bone. 2009;45:590–602.
   PubMed Web of Science ®Google Scholar
• Eli Lilly. Prescribing information of Forteo (teriparatide rDNA origin injection). [cited 2012 Mar 21]. Available from: http://pi.lilly.com/us/forteo-pi.pdf
   Google Scholar
• Sivamani RK, Liepmann D, Maibach HI. Microneedles and transdermal applications. Expert Opin Drug Deliv. 2007;4:19–25.10.1517/17425247.4.1.19
   PubMed Web of Science ®Google Scholar
• Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA. 2008;105:2058–2063.10.1073/pnas.0710355105
   PubMed Web of Science ®Google Scholar
• Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev. 2001;46:281–305.10.1016/S0169-409X(00)00138-1
   PubMed Web of Science ®Google Scholar
• Park EJ, Werner J, Smith NB. Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm Res. 2007;24:1396–1401.10.1007/s11095-007-9306-4
   PubMed Web of Science ®Google Scholar
• Kim KS, Kim H, Park Y, et al. Noninvasive transdermal vaccination using hyaluronan nanocarriers and laser adjuvant. Adv Funct Mater. 2016;26:2512–2522.10.1002/adfm.v26.15
   PubMed Web of Science ®Google Scholar
• Jung HS, Kong WH, Sung DK, et al. Nanographene oxide–hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. ACS Nano. 2014;8:260–268.10.1021/nn405383a
   PubMed Web of Science ®Google Scholar
• Yang JA, Kim ES, Kwon JH, et al. Transdermal delivery of hyaluronic acid – human growth hormone conjugate. Biomaterials. 2012;33:5947–5954.10.1016/j.biomaterials.2012.05.003
   PubMed Web of Science ®Google Scholar
• Laurent TC. The chemistry, biology and medical applications of hyaluronan and its derivatives. London: Portland Press; 1998.
   Google Scholar
• Laurent TC. Structure of hyaluronic acid. In: Balazs EA, editor. Chemistry and molecular biology of the intercellular matrix. London: Academic Press; 1970. p. 703–728.
   Google Scholar
• Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev. 1978;58:255–315.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Hahn SK, Kim MJ, et al. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles. J Control Rel. 2005;104:323–335.10.1016/j.jconrel.2005.02.012
   PubMed Web of Science ®Google Scholar
• Motokawa K, Hahn SK, Nakamura T, et al. Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin. J Biomed Mater Res. 2006;78A:459–465.10.1002/(ISSN)1552-4965
   Web of Science ®Google Scholar
• Nakamura T, Kato T, Togawa H, et al. Conjugate of water-soluble modified hyaluronic acid and GLP-1 analogue. International patent WO/2006/095775. 2006 Aug 03.
   Google Scholar
• Brown MB, Jones SA. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venerol. 2005;19:308–318.10.1111/jdv.2005.19.issue-3
   PubMed Web of Science ®Google Scholar
• Jia X, Colombo G, Padera R, et al. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials. 2004;25:4797–4804.10.1016/j.biomaterials.2003.12.012
   PubMed Web of Science ®Google Scholar
• Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol. 2011;22:216–224.10.1681/ASN.2010020186
   PubMed Web of Science ®Google Scholar
• Souberbielle JC, Roth H, Fouque DP. Parathyroid hormone measurement in CKD. Kidney Int. 2010;77:93–100.10.1038/ki.2009.374
   PubMed Web of Science ®Google Scholar
• Alberts B, Johnson A, Lewis J, et al. Essential cell biology. 2nd ed. New York (NY): Garland Science; 2004.
   Google Scholar
• Dolson GM, Hise MK, Weinman EJ. Relationship among parathyroid hormone, cAMP, and calcium on proximal tubule sodium transport. Am J Physiol. 1985;249:409–416.
   Google Scholar
• Yamaguchi DT, Hahn TJ, Iida-Klein A, et al. Parathyroid hormone-activated calcium channels in an osteoblast-like clonal osteosarcoma cell line. J Biol Chem. 1987;262:7711–7718.
   PubMed Web of Science ®Google Scholar
• Maeda S, Wu S, Juppner H, et al. Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology. 1996;137:3154–3162.10.1210/endo.137.8.8754733
   PubMed Web of Science ®Google Scholar
• Kawano M, Ariyoshi W, Iwanaga K, et al. Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid. Biochem Biophys Res Commun. 2011;405:575–580.10.1016/j.bbrc.2011.01.071
   PubMed Web of Science ®Google Scholar
• Huang L, Cheng YY, Koo PL, et al. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. J Biomed Mater Res A. 2003;66:880–884.10.1002/(ISSN)1097-4636
   PubMedGoogle Scholar
• Ponnuraj K, Jedrzejas MJ. Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J Mol Biol. 2000;299:885–895.10.1006/jmbi.2000.3817
   PubMed Web of Science ®Google Scholar